(Q77093398)
Statements
Phase I and pharmacokinetic study of the water-soluble dolastatin 15 analog LU103793 in patients with advanced solid malignancies (English)
M A Villalona-Calero
L Hammond
C Aylesworth
S G Eckhardt
M Kraynak
R Fram
S Fischkoff
R Velagapudi
D Toppmeyer
B Razvillas
K Jakimowicz
D D Von Hoff